Skip to main content

Table 2 Molecular characteristics of colon adenocarcinoma patients

From: Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

Feature Classification n (%)
MGMT methylation status Unmethylated 24 (21.8)
  Methylated 86 (78.2)
Percentage MGMT expression Low 55 (48.2)
  High 59 (51.8)
MGMT expression intensity Low 30 (26.3)
  High 84 (73.7)
Percentage CD133 expression Low 52 (47.3)
  High 58 (52.7)
CD133 expression intensity Low 70 (63.6)
  High 40 (36.4)
  1. Sample size for MGMT methylation status (n = 110), for percentage MGMT expression (n = 114), MGMT expression intensity (n = 114), percentage CD133 expression (n = 110), and CD133 expression intensity (n = 110).